Filing Details
- Accession Number:
- 0001255627-20-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-10 17:35:49
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-10 17:35:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1255627 | David Schreiber | C/O Aspira Women'S Health Inc. 12117 Bee Caves Rd Bldg 3 Ste 100 Austin TX 78738 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-08 | 50,000 | $2.78 | 185,018 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The proceeds are intended to cover tax liability for restricted stock units of Aspira Women's Health Inc. received in 2020.
- The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.75 to $2.85 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.